• Claire obtained her PhD in Hemato-Oncology in 2017 from Institut Curie/Université Paris Diderot for her work on a signalling pathway involved in T cell leukaemia.
  • She holds a postgraduate degree in Biopharmaceutical Management from ESCP Business School and obtained her MSc degree from the French Engineering School Agrocampus Ouest in 2013.
  • Claire joined Andera Partners in 2018.
  • She speaks French and English.